Advertisement

Herzkrankheiten pp 1550-1574 | Cite as

Diätetische Maßnahmen und Lipidsenkung

  • A. Weisswange

Zusammenfassung

Die Europäische Arteriosklerosegesellschaft (Task Force for Prevention of CHD, 1992) und das Amerikanische nationale Cholesterinerziehungsprogramm (NCEP 1994) haben frühere Richtlinien überarbeitet und neu formuliert.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Al Jabouri MA, Briston PG, Sinclair D et al (1994) Myxoedema revealed by simvastatin-induced myopathy. Br J Med 308:588Google Scholar
  2. Allen KGD, Klevay LM (1994) Copper: An antioxidant nutrient for cardiovascular health. Curr Opin Lipidol 5:22PubMedGoogle Scholar
  3. Anderson KM, Wilson PWF, Odell PM, Kannel WB (1991) An updated coronary risk profile. A statement for health professionals. Circulation 83:356PubMedGoogle Scholar
  4. Anderson TJ, Meredith IT, Yeung AC et al (1995 b) The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332:488PubMedGoogle Scholar
  5. Anderson JW, Johnstone BM, Cook-Newell ME (1995 a) Metaanalysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276PubMedGoogle Scholar
  6. Anthony MS, Burke GL, Hughes CL, Clarkson TB (1995) Does soy supplement improve coronary heart disease risk? (Abstract) Circulation 91:925Google Scholar
  7. Armstrong VM, Windisch M, Wieland H et al (1983) Selective continuous extracorporal elimination of low density lipoproteins with heparin at acidic pH. Trans Amer Soc artif inter Org 29:323Google Scholar
  8. Armstong VW, Schuff-Werner P, Eisenhauer T et al (1994) Heparin extracorporeal LDL precipitation (HELP): an effective apheresis procedure for lowering Lp(a) levels. Chem Phys Lipids 67/68:315Google Scholar
  9. Ascherio A, Hennekens CH, Buring JE et al (1994) Trans-fatty acids intake and risk of myocardial infarction. Circulation 89:94PubMedGoogle Scholar
  10. Ascherio A, Rimm EB, Stampfer MJ et al (1995) Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 332:977PubMedGoogle Scholar
  11. The ATBC Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the influence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029Google Scholar
  12. Azzarito C, Boiardi L, Zini M et al (1992) Long-term therapy with high-dose simvastatin does not affect adrenocortical and gonadal hormones in hypercholesterolemic patients. Metabolism 41:148PubMedGoogle Scholar
  13. Baghurst KI, Raj MJ, Truswell AS (1977) Platelet aggregation (letter). Lancet 1977/1:101PubMedGoogle Scholar
  14. Bairati I, Roy L, Meyer F (1992) Double-blind randomized controlled trial of fish oil supplements in prevention of the recurrence of stenosis after coronary angioplasty. Circulation 85:950PubMedGoogle Scholar
  15. Bak AA, Grobbee BE (1989) The effect on serum cholesterol levels of coffee brewed by filtering or boiling. N Engl J Med 321:1432PubMedGoogle Scholar
  16. Ballantyne CM, Radovanevic B, Farmer JA et al (1992) Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations. J Am Coll Cardiol 19:1315PubMedGoogle Scholar
  17. Baumstark MW, Aristegie R, Zoller T et al (1992) Probucol, incorporated into LDL particles in vivo, inhibits generation of lipid peroxides more effectively than endogenous antioxidant alone. Clin Biochem 25:395PubMedGoogle Scholar
  18. Behrens-Baumann W, Thiery J, Wieland E et al (1992) 3-Hydroxy-3-methylglutanyl coenzym A reductase inhibitor simvastatin in the human lens: Clinical results of a 3-year-follow-up. Arzneimittelforsch 42:1023PubMedGoogle Scholar
  19. Beilin LJ (1993) Vegetarian diets, alcohol consumption and hypertension. Ann NY Acad Sci 676:83PubMedGoogle Scholar
  20. Bellamy CM, Schofield PM, Faragher EB et al (1992) Can supplementation of diet with omega-3-polyunsaturated fatty acids reduce coronary angioplasty restenosis rate? Eur heart J 13:1626PubMedGoogle Scholar
  21. Berry EM, Eisenberg S, Haratz D et al (1991) Effects of diet, rich in monounsaturated fatty acids on plasma-lipoproteins. The Jerusalem Nutrition Study. High MUFAS versus high PUFAS. Am J clin nutr 53:899PubMedGoogle Scholar
  22. Berry EM, Eisenberg S, Friedlaender Y et al (1992) Effects of diet, rich in monounsaturated fatty acids on plasma-lipoproteins. The Jerusalem Nutrition Study. II: Monounsaturated versus carbohydrates. Am J clin nutr 56:394PubMedGoogle Scholar
  23. Bilheimer DW, Goldstein JL, Grundy SC et al (1984) Liver transplantation provides low density lipoprotein receptors and lowers plasma cholesterol in a child with homozygous familial hyper-cholesterolemia. N Engl J Med 311:1658PubMedGoogle Scholar
  24. Bonaa KH, Bjerve KS, Straume B et al (1990) Effect of eicosapentaenoic and docosahexaenoic acid in blood pressure in hypertension. N Engl J Med 322:795PubMedGoogle Scholar
  25. Bradfort RH, Shear CL, Chremos AN et al (1991a) Expanded clinical evaluation of lovastatin (EXCEL) Study Results I. Efficacy in modifying plasma lipoprotein and adverse event profile in 8245 patients with moderate hypercholestolemia. Arch Intern Med 151:43Google Scholar
  26. Bradfort RH, Shear CL, Chremos AN et al (1991b) Expanded clinical evaluation of lovastatin (EXCEL) Study Results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia. Am J Med 91 (Suppl IB):18Google Scholar
  27. Buchwald H, Matts JP, Fitch LL et al (1992) Changes in sequential coronary arteriograms and subsequent coronary events. Surgical control of the hyperlipidemias (POSCH) group. J Am Med Ass 268:1429Google Scholar
  28. Burr ML, Fehily AM, Gilbert JF et al (1989) Effect of changes in fat, fish and fiber intakes on death and myocardial infarction. Diet And Reinfarction Trial (DART). Lancet 334:751Google Scholar
  29. Carlsson LA, Hamsten A, Asplund A (1989) Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidemic subjects treated with nicotinic acid. J Intern Med 226:271Google Scholar
  30. Cerda JJ, Normann SJ, Sullivan MP et al (1994) Inhibition of atherosclerosis by dietary pectin in microswine with sustained hypercholesterolemia. Circulation 89:1247PubMedGoogle Scholar
  31. Chang-Claude J, Frentzel-Beyme R, Eilber U (1992) Mortality pattern of German vegetarians after 11 years of follow-up. Epidemiology 2:395Google Scholar
  32. Chang-Claude J, Frentzel-Beyme R (1993) Dietary and lifestyle determinants of mortality among German vegatarians. Int J Epidemiol 22:228PubMedGoogle Scholar
  33. Chisholm A (1993) The role of diet in patients who are on lipid-lowering drug therapy. Curr Opin Lipidol 4:17Google Scholar
  34. Colditz GA, Hankinson SE, Hunter DJ et al (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332:1589PubMedGoogle Scholar
  35. Committee of Principal Investigators, WHO (1978) A co-operative trial on the primary preventions of ischemic heart disease using Clofibrate. Br Heart J 40:1069Google Scholar
  36. Connor WE, Connor SL (1989) Dietary treatment of familial hypercholesterolemia. Arteriosclerosis 9 (Supp 1):91Google Scholar
  37. Connor WE, Connor SL (1993) Importance of diet in the treatment of familial hypercholesterolemia. Am J Cardiol 72 (Suppl D):42DGoogle Scholar
  38. Connor WE, Connor SL (1989) Dietary treatment of hypercholesterolemia. Arteriosclerosis 9 (Supp 1):91Google Scholar
  39. Coronary Drug Project Research Group (1975) Clofibrate and niacin. J Am Med Ass 72 (Supp D):42Google Scholar
  40. Coronary Drug Project Research Group (1986) Fifteen year mortality coronary drug project patients: Long-term benefits with niacin. J Am Coll Cardiol 8:1245Google Scholar
  41. Crepaldi G, Fellini R, Briani G (1982) Treatment of type II and type IV Fredrickson’s hyperlipoproteinemia. Adv exp Med Biol 38:199Google Scholar
  42. Criqui MH, Ringel BL (1994) Does diet or alcohol explain the French paradox? Lancet 344:1719PubMedGoogle Scholar
  43. Dachet C, Jacotot B, Buxtorf JC (1985) The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type Ha hyperlipoproteinemia. Atherosclerosis 58:261PubMedGoogle Scholar
  44. Dehmer GJ, Popma JJ, Berg EK van den et al (1988) Reduction in the early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 319:733PubMedGoogle Scholar
  45. Descovic GD, Ceredi C, Gaddi A et al (1980) Multicenter study of soybean protein diet for outpatient hypercholesterolemic patients. Lancet 2:709Google Scholar
  46. Dolecek TA (1991) Epidemiological evidence of relationsships between dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial. Proc Soc Exp Biol Med 200:177Google Scholar
  47. Drexler H, Zeiher AM, Meinzer K, Just H (1991) Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-Arginine. Lancet 338:1546PubMedGoogle Scholar
  48. Ducimetière P, Guize L, Marciniak A et al (1993) Arteriographically dodumented coronary artery disease and alcohol consumption in french men. Teh CORACI-Study. Eur Heart J 14:727PubMedGoogle Scholar
  49. Dujovne CA, Chremos AN, Pool JL et al (1991) Expanded clinical evaluation of lovastatin (EXCEL) Study Results IV: Additional perspectives in the tolerability of lovastatin. Am J Med 91 (Suppl IB):25Google Scholar
  50. Dyerberg J, Bang HO (1979) Lipid metabolism, atherogenesis and haemostatis in Eskimos: The role of prostaglandin-3 family. Haemostasis 8:227PubMedGoogle Scholar
  51. Emken EA (1984) Nutrition and biochemistry of trans and positional fatty acid and isomers in hydrogenated oil. Ann Rev Nutr 4:339Google Scholar
  52. Farchi G, Fidanza F, Mariotti S, Menotti A (1985) Alcohol and mortality in the Italian rural cohorts of the Seven Countries Study. Int J Epidemiol 21:74Google Scholar
  53. Farchi G, Marioti S, Menotti A et al (1989) Diet and 20 year mortality in two rural population groups of middle-aged men in Italy. Am J Clin Nutr 50:1095PubMedGoogle Scholar
  54. Frankel EN, Kanner J, German JB et al (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341:454PubMedGoogle Scholar
  55. Fraser GE, Sabaté J, Beeson NL et al (1992) A possible protective effect of nut consumption on risk of coronary heart disease. Arch Intern Med 152:1416PubMedGoogle Scholar
  56. Frick MH, Elo O, Haapa K et al (1987) Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle aged men with dylipidemia. N Engl J Med 317:1237PubMedGoogle Scholar
  57. Frost CD, Law MR, Wald NJ (1991) By how much does dietary salt reduction lower blood pressure? II. Analysis of observational data within population. Br Med J 302:815Google Scholar
  58. Grigg LE, Kay TWH, Valentine PA et al (1989) Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol 13:665PubMedGoogle Scholar
  59. Henkin Y, Obermann A, Hurst DC et al (1991) Niacin revisited: Clinical observations on an important but underutilized drug. Am J Cardiol 91:239Google Scholar
  60. Ikeda I, Tomari Y, Sugano M (1989) Effects of diatary fiber and fat on lymphatic cholesterol and triglyzeride absorption in rats. J Nutr 119:1383PubMedGoogle Scholar
  61. Illman RJ, Topping DL, Mcintosh GH et al (1988) Hyperchole-sterolemic effects of dietary propionate: Studies in whole animals and perfused rat liver. Ann Nutr Metabol 32:97Google Scholar
  62. International Task Force For Prevention of Coronary Heart Disease (1982) Prevention of coronary heart disease: Scientific background and new clinical guidelines. Recommendations of the European Arteriosclerosis Society. Nutr Metabol Cardiovasc Dis 2:113Google Scholar
  63. Jeffrey RW, Wing RR, French SA (1992) Weight cycling and cardiovascular risk factors in obese men and women. Am J Clin Nutr 55:641Google Scholar
  64. Kane JP, Malloy MJ, Ports TA et al (1990) Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. J Am Med Ass 264:3007Google Scholar
  65. Kaul U, Sanghvi S, Bahl KV et al (1992) Fish oil supplements for prevention of restenosis after coronary angioplasty. Int J Cardiol 35:87PubMedGoogle Scholar
  66. Kawachi I, Colditz GA, Stone CB (1994) Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J 72:261Google Scholar
  67. Kleinveld HA, Damecker PNM, De Haan AFJ et al (1993) Decreased oxidizability of low-density lipoprotein in hypercholerstolemic patients treated with 3-hydroxy-methylglutaryl-CoA reductase inhibitors. Eur J Clin Invest 23:289PubMedGoogle Scholar
  68. Kobashigawa JA, Katznelson S, Laks H et al (1995) Effect of pravastatin on outcome after cardiac transplantation. N Eng J Med 333:621Google Scholar
  69. Kristensen SD, Schmidt EB, Dyerberg J (1989) Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: A review with particular emphasis on im plications for cardiovascular disease. J Int Med 225 (Suppl 731):141Google Scholar
  70. Krumhout D, Bosschieter EB, Coulander CDL (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312:1205Google Scholar
  71. Latis AM, Shear CL, Lippa EA et al (1991) Expanded clinical evaluation of lovastatin (EXCEL) Study Results II: Assessment of the human lens after 48 weeks of treatment with lovastatin. Am J Cardiol 67:447Google Scholar
  72. Law MR, Frost CD, Wald NJ (1991) By how much does dietary salt reduction lower blood pressure? I. Analysis of observational data among populations. Br Med J 302:811Google Scholar
  73. Law MR, Wald NJ, Wu T et al (1994 a) Systematic underestimation of association between serum cholesterol concentration and ischemic heart disease in observational studies: data from the BUPA Study. Br J Med 308:363Google Scholar
  74. Law MR, Wald NJ, Thompson SG (1994b) By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease? Br Med J 308:367Google Scholar
  75. Law MR, Thompson SG, Wald NJ (1994 c) Assessing possible hazards of reducing serum cholesterol. Br Med J 308:373Google Scholar
  76. Leaf A (1990) Cardiovascular effects of fish oils. Circulation 82:624PubMedGoogle Scholar
  77. Leaf A, Jorgensen MB, Jacobs AK et al (1994) Do fish oils prevent restenosis after coronary angioplasty? Circulation 90:2248PubMedGoogle Scholar
  78. Leaf A, Weber PC (1988) Cardiovascular effects of n-3 fatty acids. N Engl J Med 318:549PubMedGoogle Scholar
  79. Lehr HA, Hübner C, Finckh B et al (1991) Dietary fish oil reduces leukocyte/endothelium interaction following systemic administration of oxydatively modified low density lipoprotein. Circulation 84:1725PubMedGoogle Scholar
  80. Lin DS, Connor WE (1981) The long-term effects of dietary cholesterol upon the plasma lipids, lipoproteins, cholesterol absorption, and the sterol balance in man: the demonstration of feedback inhibition of cholesterol biosynthesis and increased acid excretion. J Lipid Res 21:1042Google Scholar
  81. Lipid Research Clinics Investigators (1992) The lipids research clinics coronary primary prevention trial: Results of 6 years of post-trial follow-up. Arch Intern Med 152:1399Google Scholar
  82. de Lorgeril M, Renaud, Memelle N et al (1994) Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343:1454PubMedGoogle Scholar
  83. Lovastatin Study Group I Through IV (1993) Lovastatin 5-year safety and efficacy study. Arch intern Med 153:1293Google Scholar
  84. Maclure M (1993) Demonstration of deductive meta-analysis: Ethanol intake and risk of myocardial infarction. Epidemiol Rev 15:328PubMedGoogle Scholar
  85. Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: principal results. Brit Med J 291:97Google Scholar
  86. Mensink RP, Katan MB (1992) Effects of dietary trans-fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 323:439Google Scholar
  87. Milner MR, Gallino RA, Leffingwell A et al (1989) Usefulness of fishoil supplements in preventing clinical evidence of restenosis after percutaneous coronary angioplasty. Am J Cardiol 64:294PubMedGoogle Scholar
  88. Mitropulos KA, Miller GJ, Martin JC et al (1994) Dietary fat induces changes in factor VII coagulant activity through effects on plasma. The stearic acid concentration. Arterioscler Thromb 14:214Google Scholar
  89. Mitchell JC, Logan GM, Stone BG et al (1991) Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans. J Lipid Res 32:71PubMedGoogle Scholar
  90. Morris MC, Sacks F, Rosner B (1993) Does fish oil lower blood pressure? A metaanalysis of controlled trials. Circulation 88:523PubMedGoogle Scholar
  91. National Cholesterol Education Program (1994) Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 89:1329Google Scholar
  92. Neil A, Silagy C (1994) Garlic: Its cardioprotective properties. Curr Opin Lipidol 5:6PubMedGoogle Scholar
  93. Nestel P, Noakes M, Belling B et al (1992) Plasma lipoprotein lipid and Lp(a) changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 33:1029PubMedGoogle Scholar
  94. Nye ER, Ilsley CDJ, Ablett MB et al (1990) Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty. Austr N Z J Med 20:549Google Scholar
  95. Ornish D, Brown SE, Scherwitz LW et al (1992) Can lifestyle changes reverse coronary heart disease? Lancet 336:129Google Scholar
  96. Philips RL, Lemon FR, Beeson WL et al (1978) Coronary heart disease mortality among seventh-day adventists with differing dietary habits: A preliminary report. Am J Clin Nutr 31 (Suppl 10):191Google Scholar
  97. Pooling Project Research Group (1978) Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG-abnormalities to incidence of major coronary events: Final report of the pooling project. J chron Dis 31:201Google Scholar
  98. Princen HMG, Poppel G von, Vogelzang C et al (1992) Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid oxydation in vitro: effect of cigarette smoking. Atheriosclerosis Thromb 12:554Google Scholar
  99. Prineas RJ, Kushi LH, Folsom AR et al (1993) Walnuts and serum lipids (letter). N Engl J Med 329:359PubMedGoogle Scholar
  100. Ramsay LE, Yeo WW, Jackson PR (1991) Dietary reduction of serum cholesterol concentration: Time to think again. Br Med J 303:953Google Scholar
  101. Reis GJ, Boucher TM, Sipperly ME et al (1989) Randomized trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989/II:177Google Scholar
  102. Reis G, Pasternak R (1989) Fish oil supplements and restenosis after percutaneous transluminal coronary angioplasty. Lancet 1989/2:177PubMedGoogle Scholar
  103. Renaud S, De Lorgeril M (1992) Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 339:1523PubMedGoogle Scholar
  104. Rimm EB, Stampfer MJ, Ascherid A et al (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450PubMedGoogle Scholar
  105. Sabaté J (1993) Does nut consumption protect against ischemic heart disease. Eur J Clin Nutr 47 (Suppl 1):S71PubMedGoogle Scholar
  106. Samuel P, Steiner A (1959) Effect of neomycine in serum cholesterol level in man. Proc Soc exp Biol (NY) 100:93Google Scholar
  107. Scandinavian Simvastatin Survival Study Group (1995) Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383Google Scholar
  108. Schimke I, Haberland A (1993) Sauerstoffradikale und Herz-Kreislauf-Krankheiten: Pathogenetische Mechanismen, therapeutische Möglichkeiten. Z Kardiol 82:601PubMedGoogle Scholar
  109. Schwarzkopf W, Baeyer H von, Schwerdtfeger R, Weiss R (1984) Die Behandlung der familiären Hypercholesterinämie durch Plasmapherese oder in Kombination mit selektiver Proteinultrafiltration. Verh Dtsch Ges inn Med 90:1177Google Scholar
  110. Seidel J (1993) Risikofaktoren der Atherogenese. Mechanismen ihrer Wirkung und klinische Bewertung. Dtsch Ärztebl 90:2307Google Scholar
  111. Seidel D, Thiery J (1992) Die extrakorporale Plasmatherapie bei Fettstoffwechselstörungen: Erfahrungsbericht mit dem H.E.L.P.-System. Internist 33:54PubMedGoogle Scholar
  112. Shear CL, Franklin FA, Stinnet S (1992) Expanded clinical evaluation of lovastatin (EXCEL) Study Results. Effect of patient characteristics ans lipoproteins. Circulation 85:1293PubMedGoogle Scholar
  113. Shepherd J, Cobbe SM, Ford I et al (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:301Google Scholar
  114. Simopoulos AP, Salem N (1989) N-3 fatty acids in eggs from range-fed Greek chickens. N Engl J Med 321:1412PubMedGoogle Scholar
  115. Singh RB, Rastogi SS, Verma R et al (1992) Randomized controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow-up. Brit Med J 304:1689Google Scholar
  116. Slack JD, Pinkerton CA, Van Tassl J et al (1987) Can oral fish oil supplement minimize restenosis after percutaneous transluminal coronary angioplasty? (Abstr) J Am Coll Cardiol 9:64Google Scholar
  117. Stampfer MJ, Hennekens CH, Manson JE et al (1993) Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444PubMedGoogle Scholar
  118. Stampfer MG, Colditz GA (1991) Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 20:47PubMedGoogle Scholar
  119. Strandberg TE, Salomaa VV, Naukkarinen VA et al (1991) Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. J Am Med Ass 266:1225Google Scholar
  120. Stuyt PMJ, Mol MJTM, Stalenhoeff AFH (1991) Long-term effects of simvastatin in familial dysbetalipoproteinaemia. J Intern Med 230:151PubMedGoogle Scholar
  121. Thompson GR, Myant NB, Kilpatrik AF et al (1980) Assessment of long-term plasma exchange for familial hypercholesterolemia. Br Heart J 43:680PubMedGoogle Scholar
  122. Thorogood M (1994) Vegetarism, coronary disease risk factors and coronary heart disease. Curr Opin Lipidol 5:17PubMedGoogle Scholar
  123. Treasure CB, Klein JL, Weintraub WS et al (1995) Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332:481PubMedGoogle Scholar
  124. Uauy R, Vega GL, Grundy SM et al (1988) Lovastatin in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentration or turnover. J Pediatr 113:387PubMedGoogle Scholar
  125. Van Brummelen P, Koolen ML (1987) Difference in sodium sensitivity in human hypertensives. Clin Invest Med 10:581PubMedGoogle Scholar
  126. Wang BY, Singer AH, Tsao PS et al (1994) Dietary arginine prevents atherogenesis in the coronary artery of the hyperchole-sterolemic rabbit. J Am Coll Cardiol 23:452PubMedGoogle Scholar
  127. Watts GF, Lewis B, Bruntg JNA et al (1992) Effects on coronary artery disease of lipid lowering diet or diet plus cholestyramine in the St. Thomas Atherosclerosis Regression Study (STARS). Lancet 339:563PubMedGoogle Scholar
  128. Weidner G, Connor BSL, Chesnay MA et al (1991) Sex differences in HDL-cholesterol among low level alcohol consumers. Circulation 83:176PubMedGoogle Scholar
  129. Willet WC, Stampfer MJ, Mason JE et al (1993) Intake of trans-fatty acids and risk of coronary heart disease. Lancet 341:581Google Scholar
  130. Wilson JM, Grossman M (1993) Therapeutic strategies for familial hypercholesterolemia based on somatic gene transfer. Am J Cardiol 72:59DGoogle Scholar
  131. Writing Group of the PEPI-trial (1995) Effects of estrogen/pro-gestin regimen on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial. J Am Med Ass 273:199Google Scholar
  132. Yamamoto O, Takakusa N, Mishima Y et al (1994) Determination of the promoter region of mouse ribosomal RNA gene by an in vitro transcription system. Proc Natl Acad SCI USA 81:299Google Scholar
  133. Zook PL, Kayan MB, Merkus MP et al (1990) Effect of a lipid-rich fraction from broiled coffee on serum cholesterol. Lancet 335:1235Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • A. Weisswange

There are no affiliations available

Personalised recommendations